Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study | Zendy

Elad Goldberg | Zendy; M. Paul | Zendy; Olga Talker | Zendy; Zmira Samra | Zendy; Maryna Raskin | Zendy; Rawi Hazzan | Zendy; Leonard Leibovici | Zendy; Jihad Bishara | Zendy

Open Access

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study

Author(s) -

Elad Goldberg,

M. Paul,

Olga Talker,

Zmira Samra,

Maryna Raskin,

Rawi Hazzan,

Leonard Leibovici,

Jihad Bishara

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq179

Subject(s) - medicine , vancomycin , methicillin resistant staphylococcus aureus , retrospective cohort study , staphylococcus aureus , bacteremia , micrococcaceae , staphylococcal infections , microbiology and biotechnology , cohort , cohort study , antibacterial agent , antibiotics , bacteria , biology , genetics

To evaluate the efficacy and safety of co-trimoxazole versus that of vancomycin in adults with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research